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Recombinant adeno-associated virus (rAAV) is widely used in retinal gene therapy. Enhanced rAAV
transduction may be important for better therapeutic effects in some retinal gene therapies. In this
study, we examined the effects of adenovirus 5 (Ad5) on retina transduction mediated by rAAV2.
Our results provide the ﬁrst evidence that low levels of either replication-incompetent or conditional
replication-competent Ad5 signiﬁcantly enhance and accelerate transgene expression in human and
rat retinal cells. This effect occurs principally at the transcriptional level, rather than through enhanced
viral entry or DNA replication. In in vivo analyses with the SD rat, the Balb/c mouse, and the RCS rat,
strong enhancement and acceleration of transgene expression, as well as therapeutic effects, were con-
ﬁrmed. Low levels of Ad5 may enhance the utility of rAAV2-mediated transduction strategies in future
clinical investigations.
 2008 Elsevier Ltd. All rights reserved.1. Introduction
Retinal degenerative diseases, such as age-related macular
degeneration and retinitis pigmentosa, have become the leading
causes of blindness in adults. (Porta & Bandello, 2002; Rodriguez
et al., 2002). There is currently no effective treatment available
(Anonymous, 1991). The eye is easily accessible and allows for
local application of therapeutic vectors with a reduced risk of sys-
temic effects. Accordingly, gene therapy represents an attractive
approach in dealing with these inherited and acquired retinal
disorders (Acland et al., 2005; Pang et al., 2004; Pang et al., 2006).
Recombinant adeno-associated virus (rAAV) has been of con-
siderable interest to developers of retinal gene therapies (Alexan-
der et al., 2007; Auricchio, 2003; Bainbridge et al., 2003; Pang,
Chang, et al., 2006; Pang et al., 2008). Unlike adenoviruses, the
introduction of rAAV vectors has not induced signiﬁcant inﬂam-
mation either experimentally or clinically because these vectors
contain no viral genes. Furthermore, infection with rAAV has
not been associated with any human disease (Muzyczka, 1992).
However, the transduction of rAAV occurs with relatively low efﬁ-
ciency in some tissues, which limits its therapeutic effects (Eslamill rights reserved.
. Li); +86 21 63240825 (Q.
ng@sjtu.edu.cn (Q. Huang).et al., 2000; Vermeij et al., 2001; Zhang et al., 2008). Increasing
rAAV transduction should produce better therapeutic effects. In-
deed, early studies reported that AAV2 can replicate and assemble
in cells treated with hydroxyurea, UV or ionizing irradiation
(Alexander, Russell, & Miller, 1994). Several previous studies have
sought to enhance rAAV-mediated transduction of tumor cells by
applying chemical and physical agents such as c-rays, HDAC
inhibitors and topoisomerase inhibitors (Kanazawa et al., 2003,
2004; Kitazono, Goldsmith, Aikou, Bates, & Fojo, 2001). Originally,
it was thought that all of these agents, except HDAC inhibitors,
acted by a similar mechanism involving the conversion of AAV
single-stranded DNA into double-stranded forms. HDAC inhibi-
tors, however, might improve tumor cell transduction by enhanc-
ing the acetylation of the histone-associated chromatin of the
rAAV genome.
An alternative approach for improving rAAV-mediated trans-
duction may be provided by adenovirus. Ad (E4orf6)-enhanced
rAAV gene expression is mainly due to the increased conversion
of single-stranded rAAV2 genomes into double-stranded transcrip-
tionally active forms. Adenovirus type 5 had been shown to in-
crease the transduction efﬁciency of AAV in vitro in 293 and
tumor cell cultures (Ferrari, Samulski, Shenk, & Samulski, 1996;
Fisher et al., 1996). Recently, researchers reported that the combi-
nation of AAV-BMP2 and Ad-BMP2 produces enhanced osteogenic
activity in immunocompetent rats (Chen et al., 2004). However,
no study has directly investigated the effects of Ad5 on
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results provide the ﬁrst evidence that low-level Ad5 not only dra-
matically enhances, but also accelerates, transduction of rAAV2
vectors in retina in vitro and in vivo, with no remarkable apoptosis
or immune response. This effect occurs principally at the transcrip-
tional level, rather than through enhanced viral entry or DNA rep-
lication. Furthermore, we found that the enhancement effect of
Ad5 on rAAV2 gene expression lasts for a long time after Ad5 has
been eliminated from the retina.
2. Methods
2.1. Virus and cells
Conditional replication-competent adenovirus Ad5-TERT-E1A/E1B and replica-
tion-incompetent adenovirus Ad5-RFP were constructed and preserved by our
experimental lab (Huang, Zhang, et al., 2004; Huang, Lin, et al., 2004). These con-
structs were derived from the ﬁrst-generation E1/E3-deleted adenovirus vector. Ad-
Null (adenoviral type 5 vector backbone without cDNA insert) and the recombinant
adeno-associated viral vectors rAAV2-GFP (green ﬂuorescent protein gene), rAAV2-
Luc (luciferase gene), and rAAV2-CNTF (ciliary neurotrophic factor gene) were pur-
chased from Vector Gene Technology Company Limited (Beijing, China) (Gao et al.,
2000). Ad5-RFP, rAAV2-GFP, rAAV2-Luc, and rAAV2-CNTF express transgene under
control of the CMV promoter. Ad5-TERT-E1A/E1B expresses E1A/E1B under the con-
trol of telomerase.
Human adult retinal pigmented epithelium (RPE) cells were obtained from
adult eyes donated for corneal transplantation. Rat neural retinal cells were ob-
tained from eyes of a 1-week-old SD rat. Isolation and primary culture were per-
formed as previously described (Stramm, Haskins, McGovern, & Aguirre, 1983).
The established human RPE cell line APRE-19 (ATCC, Rockville, MD), and primary
cultured human and rat retinal cells were grown in Dulbecco’s modiﬁed Eagle’s
medium/F12 (Gibco, Grand Island, NY, USA) supplemented with 15% fetal bovine
serum at 37 C, 5% CO2.
2.2. In vitro infection and transgene expression
APRE-19 cells, primary cultured rat neural retinal cells, and primary cultured RPE
cells were seeded into 24-well plates at 1  105 cells/well, and incubated in 500 ll
growth medium for 24 h prior to infection. These cells were infected by rAAV2-GFP
alone or in combination with Ad5-TERT-E1A/E1B, Ad5-RFP or AdNull. rAAV2-GFP
was at 1000 and10,000 vector genomes per cell (vg/cell). The combined adenoviruses
includedAd5-RFP, AdNull, andAd5-TERT-E1A/E1B at amultiplicity of infection (MOI)
of 0.01, 0.1, 1, and 10 plaque-forming units per cell (PFU/cell), respectively. Here, we
used differentMOIs of AdNull and Ad5-TERT in order to ﬁnd the best dose to enhance
the GFP expression mediated by rAAV2. The uninfected cells were used as controls.
GFP expression was imaged and recorded using inverted ﬂuorescence microscopy
(Zeiss Axio 100, Jena, Germany) every 24 h post-infection. Apoptosis andGFP expres-
sion of the infected APRE-19 cells were quantitatively examined by FACS (EPICS XL,
Beckman Coulter Company, Miami, FL, USA) analysis. Propidium iodide (PI, Invitro-
gen, Carlsbad, CA, USA) was used for apoptosis evaluation.
2.3. mRNA analysis of transgene GFP and receptors for the AAV2
Total RNA was isolated from the APRE-19 cells 24, 72, and 120 h after infec-
tion with either rAAV2-GFP (104 vg/cell) alone or together with AdNull, (0.1
MOI) using Trizol reagent (Invitrogen, Carlsbad, CA, USA), and reverse-transcribed
into a single-stranded cDNA using the SuperscriptTM III First-Strand Synthesis Sys-
tem for RT-PCR (Invitrogen, Carlsbad, CA, USA). One-hundred nanograms of cDNA,
as determined by photometry at 260/280 nm, (Genequant II, Pharmacia, DuÈben-
dorf, Switzerland) was used as template for ampliﬁcation in a 50-ll reaction mix-
ture, and GFP, HSPG, FGF-R1 or alpha v integrin mRNA was then quantiﬁed by
real-time PCR (MJ Research, Waltham, MA, USA) with a Platinum SYBR Green
qPCR SuperMix UDG Kit (Invitrogen, Carlsbad, CA, USA). To normalize each sam-
ple, the copy number of the GAPDH gene was also quantiﬁed. For copy number
control standards, serial dilutions of pZac-eGFP were used. The relative target
gene expression was normalized with a calibrator (hRPE cells with treatment of
rAAV2-GFP only). The ﬁnal result, expressed as N-fold differences in target gene
expression relative to the GAPDH gene and the calibrator, was determined by
the following formula: Ntarget = 2
DDCt . The primer pairs speciﬁc for transgene
and rAAV2 receptors were described in Table 1.
2.4. Determination of transgene copy number
APRE-19 cells were infected as described above and total DNA was extracted
from the infected APRE-19 cells (DNA Extraction Kit, Invitrogen, Carlsbad, CA,
USA) when mRNA was puriﬁed. One-hundred nanograms of DNA (determined by
photometry at 260/280 nm) was added to a total of 50 ll of a reaction mixturefor ampliﬁcation using a Platinum SYBR Green qPCR SuperMix UDG Kit. The copy
number of the GAPDH gene was used as an intrinsic control. The GFP copy numbers
were then determined by real-time PCR and presented as N-fold differences to the
calibrator as described above.
2.5. Animal grouping and subretinal injection
Normal adult Sprague–Dawley (SD) rats (180–200 g), BALB/c mice (18–20 g),
and Royal College of Surgeons (RCS) rats (3-week old) were used in this experiment.
All animals were treated, maintained, and sacriﬁced in accordance with the policies
stated in the ARVO Statement for the Use of Animals in Ophthalmic and Vision Re-
search and the guidelines approved by national and local institutions. SD and RCS
rats were anesthetized with intraperitoneal injection of 10% chloral hydrate and
BALB/c mice with 0.1% sodium pentobarbital. Surgical procedures and post-surgery
care were performed as described previously (Duisit et al., 2002; Zhang et al., 2008).
Brieﬂy, eyes were gently protruded using a rubber circle and subsequently covered
with 2% hydroxypropylmethylcellulose in PBS. The tip of a 1.5-cm, 28-gauge needle
was inserted 1 mm posterior to the corneal limbus causing a self-sealing wound
tunnel. Trans-sclera subretinal injection of 2 ll viral suspension or PBS was made
by introducing a blunt 32-gauge Hamilton syringe through the sclera, vitreous into
subretinal space in the superior retina. Eyes of SD rats, BALB/c mice and RCS rats
were injected with rAAV2-GFP, rAAV2-LUC or rAAV2-CNTF alone or combined with
AdNull, respectively. Control eyes were not injected or were injected with PBS. The
doses of viral vectors included rAAV2-GFP 1  109 vg/eye, rAAV2-Luc 1  109 vg/
eye, rAAV2-CNTF 1  109 vg/eye, and AdNull 1  104 PFU/eye. Approximately 250
normal SD rats, 25 BALB/c mice and 54 130 RCS rats were used in this study.
2.6. Bioluminescence and ﬂuorescence imaging in vivo retina
GFP ﬂuorescence expression in the ocular fundus of live SD rats was monitored
and photographed by ﬂuorescent stereoscope (LEICA MZFLIII, Jena, Germany) on
days 1, 3, 7, 14, 30, 60, 120, and 180 days post-injection. ImagePro Plus Software
(Media Cybernetics, Silver Spring, MD) was used to analyze and quantify the area
and mean density of GFP ﬂuorescence. Data are presented as IOD (total area mean
density of GFP ﬂuorescence). Bioluminescence imaging of luciferase in the eyes of
BALB/c mice was performed by the in vivo imaging system (Roper, Scientiﬁc, Tren-
ton, NJ, USA) 1, 7, 15, 30, 120, and 300 days post-injection.
2.7. Tissue processing and HE staining
SD and RCS rats were sacriﬁced with an overdose intraperitoneal injection of
10% chloral hydrate 8 weeks after subretinal injection. After enucleation, eyes were
ﬁxed in 10% formaldehyde solution, embedded in parafﬁn, and then sectioned into
5 lm thick fragments. Sections were stained with hematoxylin and eosin to observe
retinal architecture, inﬂammatory cell inﬁltration, and retinal thickening using ﬂuo-
rescence microscopy (ZEISS AXIOPLAN 2 imaging, Jena, Germany).
2.8. Morphometric analysis of photoreceptor layers in RCS rats
Morphometric analysis of the outer nuclear layer (ONL) in RCS retina was per-
formed with Imagepro Plus Software. The measurements were taken in both the
temporal and nasal halves of the retinas as described previously (Michon, Li, Shio-
ura, Anderson, & Tso, 1991). Three deﬁned regions were selected in each hemi-
sphere under a 5 objective for measurements of ONL thickness. Two regions
were separated by a distance of 300 lm from the ora serrata and optic nerve head,
and the third was at the midpoint. Three measurements were taken for each region
in ﬁve consecutive sections under a 40 objective with a bright light. The mean of
these values was used as the estimate of ONL thickness. To conﬁrm the measure-
ments of ONL thickness, the numbers of rows of nuclei in the vertical column of
the ONL were counted at the same areas, again making multiple counts in multiple
consecutive sections. The mean of these values was used as the estimate of photo-
receptor nuclei rows in each half of the retina. The data were processed for statis-
tical signiﬁcance using the paired Student’s t test.
2.9. Western blot analysis
APRE-19 cells (1  105), infected with 104 MOI rAAV2-GFP only or in combina-
tion with 0.1 MOI AdNull, were collected 7 days after infection. Royal College of Sur-
geons (RCS) rats were decapitated 8 weeks after subretinal space injection, as
described above, and the retinas were carefully dissected. hRPE cells and retinas
were incubated on ice for 15 min with lysis buffer. Samples were centrifuged at
12,000 rpm for 10 min at 4 C, and the supernatants containing solubilized protein
extracts were collected. Each sample was denatured for 5 min at 95 C in loading
buffer. Equal amounts of 2 lg protein were then loaded for each sample in all lanes
and separated on SDS–PAGE followed by transfer to a polyvinylidene ﬂuoride
(PVDF) membrane. The membrane was then incubated with either a mouse mono-
clonal antibody against GFP (MBL, 1:10,000) or goat polyclonal antibody against
CNTF (1:2000, Santa Cruz Biotechnology, Santa Cruz, CA, USA) diluted in 5%
milk. The probed PVDF membrane was incubated with anti-mouse or anti-goat
Table 1
Primer sets for real-time PCR
Former Reverse Amplicon size (bp)
GFP 50-AGAAGAACGGCATCAAGGTG-30 50-GAACTCCAGCAGGACCATGT-30 200
HSPG 50-CGATGACTACGCTTCTGC-30 50-TATCCTCTTCGGCTGGGT-30 209
FGF-R1 50-CCTACTTCTCCGTCAATGTTT-30 50-CACTGGAAGGGCATTTGAAC-30 210
Alpha v integrin 50-AGGCAGTGCTATTCCCAGTA-30 50-CCCGTAACTCTGGTCACATA-30 199
GAPDH 50-ATGGAAATCCCATCACCATCTT-30 50-CGCCCACTTGATTTTGG-30 241
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USA) and developed by ECL Western blotting detection reagents (Amersham Phar-
macia Biotech, Piscataway, NJ, USA).3. Results
3.1. Effects of adenovirus 5 on rAAV2-mediated transgene expression
in vitro
To analyze whether a lower dose of adenovirus 5 (replication-
competent or replication-incompetent Ad5) can improve rAAV2-
mediated gene expression in retinal cells, we transduced
APRE-19 cells, primary cultured human RPE cells, and rat neural
retinal cells with rAAV2-GFP in the presence and absence of Ad-
Null or Ad5-TERT-E1A/E1B. We found that either AdNull or Ad5-
TERT-E1A/E1B improved rAAV2-mediated gene expression in a
dose-dependent manner by enhancing both the amount of
GFP-positive cells and the intensity of GFP expression (Fig. 1A
and B). The increment of GFP expression was further conﬁrmed
by Western blotting (Fig. 1C). MOI (0.1) AdNull produced similar
effects on rAAV2-mediated gene expression compared to 0.01
MOI Ad5-TERT-E1A/E1B. No apparent cellular apoptosis was de-
tected by FACS when the titer of Ad5 was less than 10 MOI (Ad-
Null) or 1 MOI (Ad5-TERT-E1A/E1B) in the combined
transduction compared to transduction with rAAV2-GFP only
(data not shown). To study whether Ad5 might exert a sustained
effect on rAAV2-mediated gene expression and to assess the
kinetics of the effect, we conducted an experiment in which
APRE-19 cells were transduced with rAAV2-GFP, in the presence
or absence of 0.1 MOI AdNull, and then harvested for FACS anal-
ysis 1, 3, 5, 7, 10 or 12 days post-infection. This revealed that
earlier onset of gene expression mediated by rAAV2-GFP oc-
curred with the assistance of AdNull. Also, the enhancement of
transgene expression depended on the incubation period and re-
quired 7 days for the expression to reach a plateau. Furthermore,
our results showed that GFP expression levels in rAAV2-GFP
with AdNull-infected cells were more than 4-fold higher at all
time points compared to rAAV2-GFP infected cells (Fig. 1D). To
examine whether the enhancement of rAAV2-mediated gene
expression was due to Ad5 directly entering the cells, we trans-
duced APRE-19 cells with a combination of rAAV2-GFP and 0.1
MOI Ad5-RFP (Fig. 1E). Most APRE-19 cells expressing GFP did
not display RFP ﬂuorescence, and the cells expressing RFP ﬂuo-
rescence were not always observed with GFP ﬂuorescence. In-
deed, a very small proportion of cells expressed both GFP and
RFP ﬂuorescence at the same time.
3.2. Effects on receptor expression
To determine whether AdNull acted by enhancing the entry of
rAAV2, we infected APRE-19 cells with rAAV2-GFP combined
with or without 1 MOI AdNull, and then analyzed the level of
fundamental receptor HSPG and co-receptors alpha v integrin
and ﬁbroblast growth factor receptor 1 (FGF-R1) at various times
after infection by real-time quantitative PCR. This analysis dem-
onstrated that AdNull modestly enhanced the mRNA levels ofHSPG, alpha v integrin and FGF-R1, although the augmentation
was not enough to explain the drastic increase in expression
(Table 2).
3.3. Effects on rAAV2 copy number and transgene mRNA
To investigate whether AdNull might exert its effects on gene
expression at the DNA duplication or mRNA transcription level,
we performed quantitative real-time PCR and RT-PCR analyses of
rAAV2-mediated transgene expression in APRE-19 cells. To do so,
cells were harvested 24, 72, and 120 h after transduction with
rAAV2-GFP either alone or in combination with 0.1 MOI AdNull.
We found that combination with AdNull resulted in more than a
4-fold increase in GFP mRNA levels (at 120 h) compared to trans-
duction with rAAV2-GFP alone. However, AdNull did not signiﬁ-
cantly affect the copy number of the rAAV2 (Table 2). These data
suggest that AdNull’s major effect on rAAV2-mediated gene
expression occurs at the level of gene transcription, and not at
the DNA replication level.
3.4. Ad5-assisted enhancement and acceleration of rAAV2-mediated
gene expression in retina in vivo
In the analysis using optical bioluminescence imaging of Balb/c
mice, we found drastic enhancement and acceleration of luciferase
gene expression in retinas with subretinal injections of rAAV2-Luc
combined with AdNull, compared to subretinal injection of rAAV2-
Luc only (Fig. 2A). Combination of AdNull substantially increased
rAAV2-mediated luciferase expression at early time points post-
injection and exerted a positive effect on gene expression at later
time points. The fact that AdNull enhanced rAAV2-mediated gene
expression in the live retina was further conﬁrmed by ﬂuorescent
stereoscope imaging of SD retina after subretinal injection of
rAAV2-GFP with or without AdNull (Fig. 2B and C). From these re-
sults, we determined that the combination of AdNull resulted in a
signiﬁcant chronic increase of GFP expression. These data strongly
suggest the potential utility of AdNull for improving expression
levels from rAAV2-mediated gene transfer in the retina in vivo.
3.5. Ad5-assisted enhancement of photoreceptor survival in RCS rat
To assess whether subretinal administration of rAAV2-CNTF
combined with a lower dosage of Ad5 could enhance the protec-
tive effect against retinal degeneration disease, we performed an
experiment in which RCS rats were subjected to a subretinal
injection of rAAV2-CNTF with or without AdNull. Uninjected or
PBS-injected eyes were used as controls. Histological examina-
tion showed obvious preservation of photoreceptors in the
rAAV2-CNTF with AdNull injected eyes, in comparison with
either rAAV2-CNTF injected, (2–3 rows of photoreceptor nuclei)
PBS-injected, or uninjected eyes (Fig. 3A, Supplementary Table).
Morphometric analyses revealed signiﬁcant differences in the
thickness of the outer nuclear layer (ONL) and the number of
rows of nuclei in the ONL among the rAAV2-CNTF with Ad5-Null
injected, the rAAV2-CNTF alone injected, and the PBS-injected or
the non-injected eyes (P < .01) (Supplementary Table).
Fig. 1. Ad5-enhanced rAAV2-mediated transgene expression in retinal cells. (A) FACS analysis of the APRE-19 cells 7 days after infection with rAAV2-GFP alone or combined
with either AdNull or Ad5-TERT-E1A/E1B at various titer. (B) GFP expression in APRE-19 cells, primary cultured human and rat retinal cells was observed 7 days after
infection. (C) Western blot analysis of GFP expression in the APRE-19 cells 7 days after infection. (D) FACS analysis of the APRE-19 cells at various times after infection. (E) GFP
and RFP expression in the APRE-19 cells was observed 7 days after infection with rAAV2-GFP alone or combined with Ad-RFP. The cells were infected with rAAV2-GFP at
1  104 vg/cell in all the above experiments. The doses of Ad5 included 0.1 MOI AdNull in (B), (C), (D) and 0.1 MOI Ad5-RPE in (E). Scale bar represents 100 lm.
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due to an increase in CNTF production in the eyes injected withrAAV2-CNTF and AdNull, we performed a Western blot analysis
using a commercially available antibody to CNTF. This revealed
Table 2
Relative DNA copy number of GFP and mRNA expression of GFP, HSPG, alpha v
integrin, and FGF-R1 in APRE-19 cells infected with rAAV2-GFP and AdNull
Gene of interest Ntarget = 2
DDCt
24 h 72 h 120 h
AAV genome 1.05 ± 0.17 1.12 ± 0.24 1.08 ± 0.26
AAV mRNA 1.03 ± 0.16 1.07 ± 0.41 4.85 ± 0.89
HSPG mRNA 1.32 ± 0.24 1.50 ± 0.74 1.97 ± 1.11
Integrin mRNA 1.25 ± 0.46 1.37 ± 0.48 1.44 ± 0.70
FGFR-1 mRNA 1.36 ± 0.57 1.24 ± 0.79 1.56 ± 0.80
The ﬁnal result was expressed as N-fold differences in target gene expression rel-
ative to the GAPDH gene and the calibrator.
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nounced increase in CNTF expression in live rat retinas relative
to simple applications of rAAV2-CNTF (Fig. 3B).
3.6. Immune response of subretinal injection of a low dosage of AdNull
One concern was whether there were any negative effects on
the retina from the combination of rAAV2-CNTF and AdNull. To
evaluate this, the treatment-injected eyes of SD and RCS rats were
stained with hematoxylin and eosin, and histological observations
were performed. In these experiments, there was no obvious tissue
damage in the retinal sections. No obvious accumulation or inﬁl-
tration of inﬂammatory cells was observed in the host retina. These
data suggested that the combination of rAAV2 and a lower dose of
AdNull cannot induce a severe immune response. These results
were consistent with reports from other groups which used
adenovirus as a gene delivery vehicle to treat retinal degeneration
(Huang, Zhang, et al., 2004; Huang, Lin, et al., 2004).
4. Discussion
The results presented here indicate that a lower level of Ad5 can
exert a signiﬁcant enhancing and accelerating effect on rAAV2-
mediated gene expression in retinal cells, and that this effect oc-Fig. 2. Ad5-assisted enhancement of rAAV2-mediated gene expression in retina in viv
expression in the fundus of SD rats after subretinal injection. Scale bar represents 100 mm
IOD (total area mean density of GFP ﬂuorescence). The doses of viral vectors includedcurs principally at the transcriptional level rather than via en-
hanced viral entry or DNA replication. Furthermore, the
relationship between Ad5 entering cells and rAAV2 transgene
expression was preliminarily demonstrated by combining rAAV2-
GFP and Ad-RFP infections. In the analysis with the normal SD
rat, the Balb/c mouse, and the retinitis pigmentosa (RP) model of
RCS rats, strong enhancement of transgene expression, as well as
therapeutic effects, was conﬁrmed in vivo.
The application of rAAV2 vectors to retinal gene therapy is lim-
ited by their relatively low transduction efﬁciency. Several previ-
ous studies have reported that genotoxic chemicals, such as
hydroxyurea and DNA-damaging agents, including c- and UV-irra-
diation, increased rAAV2 transduction (Kim et al., 2005; Zhao et al.,
2006), but these treatments also produced signiﬁcant cytotoxicity
(Maloney et al., 2006; Yakobson, Koch, & Winocour, 1987). Indeed,
early studies have reported that several viruses can assist in AAV
growth and productive replication (Ferrari et al., 1996; Fisher et
al., 1996). This fact was further conﬁrmed by an experiment which
showed that the combination of rAAV2-BMP and Ad5-BMP pro-
duces enhanced osteogenic activity in immunocompetent rats
(Chen et al., 2004). A study conducted by Borras et al. demon-
strated that 4E1/E3 adenoviruses dramatically enhanced trans-
duction of rAAV2 in human trabecular meshwork (Borras et al.,
2006). However, there has been no direct investigation of the ef-
fects of Ad5 on the rAAV2-mediated gene expression in retinal
cells. In this report, we showed that low-level Ad5-enhanced and
accelerated transduction by rAAV2 vectors in the retina in vitro
and in vivo, with neither remarkable apoptosis nor an immune
response.
Ad5 improved the rAAV2-mediated gene transfer in a dose-
dependent manner, regardless of conditional replication-compe-
tent (Ad5-TERT-E1A/E1B) or replication-incompetent (AdNull),
and the highest enhancement was observed in retinal cells infected
by rAAV2-GFP combined with either 0.1 MOI AdNull or 0.01 MOI
Ad5-TERT-E1A/E1B. APRE-19 cultures exposed to 0.1 MOI AdNull
were transduced at 4- to 10-fold higher rates, and roughly 3- to
5-fold increases were observed in transgene mRNA expression.
Enhancement of receptor levels was modest, and the copy numbero. (A) Bioluminescence imaging of Balb/c mice after subretinal injection. (B) GFP
. (C) Quantitative analysis of GFP ﬂuorescence in SD rat retina. Data are presented as
rAAV2-Luc 1  109 vg/eye, rAAV2-GFP 1  109 vg/eye, AdNull 1  104 PFU/eye.
Fig. 3. Enhancement of photoreceptor survival of RCS rat 8 weeks after subretinal injection of rAAV2-CNTF (1  109 vg/eye) combined with AdNull (1  104 PFU/eye). (A)
Histological observations of photoreceptor nuclei using HE staining. (B) CNTF expression in RCS rat eyes was detected by Western blotting. Scale bar represents 50 lm.
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by the combination of AdNull. Viewed in this light, the superior
transduction induced by Ad5 was actually due to an enhancement
of transgene expression principally at the transcriptional level,
rather than enhanced viral entry or DNA replication. These obser-
vations were concordant with previously reported ﬁndings, which
have shown that an HDAC inhibitor, a kind of chemical agent, can
enhance rAAV-mediated gene expression at the mRNA level (Oka-
da et al., 2006).
The molecular mechanism of increased rAAV-mediated gene
expression in retinal cells remains to be determined. Early studies
demonstrated that the enhancement of adenovirus for in vitro AAV
transduction was neither facilitated by adenovirus-mediated viral
uptake nor dependent on the AAV gene cassette, but was instead
dependent on adenovirus gene products (Allen, Halbert, & Miller,
2000; Nayak & Pintel, 2007). Indeed, it had been documented that
the conversion of single-stranded rAAV2 genomes into double-
stranded transcriptionally active forms was a rate-limiting step
both in vitro and in vivo. This step could be enhanced either by
co-infecting the cells with adenovirus or by introducing the E4
(orf6) gene alone (Fisher et al., 1996). Enhancement by the E1 gene
was also observed in conjunction with E4 (orf6), and expression of
the orf6 from E4 in the absence of E1 accomplished a similar, but
attenuated effect. In the present study, the E1 and E3 adenovirus
regions of AdNull had already been deleted, and the E1A and E1B
region in Ad5-TERT-E1A/E1B had been controlled by telomerase,
although they both possessed the E4 (orf6) region. In this context,
E4/ORF6 in AdNull or E4/ORF6 together with E1 in Ad5-TERT-E1A/
E1B might play a pivotal role in the dramatic enhancement of
rAAV2-mediated transduction in retinal cells. The results from
our study also suggested that the E4ORF6 gene is an essential ele-
ment, but that the E1 gene can further enhance rAAV-mediated
transgene expression, which is consistent with previous reports
(Fisher et al., 1996).
Interestingly, a very small proportion of APRE-19 cells in-
fected by rAAV2-GFP combined with Ad5-RFP presented both
RFP and GFP ﬂuorescence. In fact, many cells which expressed
increased GFP ﬂuorescence did not show RFP ﬂuorescence atall. There are two possible explanations regarding the unex-
pressed-RFP cells: Ad5 had not entered these cells; alternatively,
the amount of Ad5 to enter the cells was too small to be ob-
served with RFP ﬂuorescence using the inverted ﬂuorescence
microscope. Based on the fact that less than one particle per cell
Ad5-RFP had been used for combinational infection, we deduced
that the former could be more reasonable. It remained to be
conﬁrmed whether these data suggested that Ad5 could inﬂu-
ence rAAV2 transgene expression not only by physical Ad gene
product presence in the rAAV transduced cells, but also by inter-
action between Ad infected and uninfected cells that would sen-
sitize uninfected cells to rAAV transduction. Whether it was
caused by secreted factors or direct interaction between Ad in-
fected and uninfected cells needs to be further investigated. This
result complemented and extended the previous notion regard-
ing Ad5-enhanced AAV2 gene expression.
The ﬁndings of this study in vivo demonstrated that the combi-
nation of both rAAV2 and low-level AdNull improved rAAV2 gene
transfer efﬁciency in the retina without causing severe immune re-
sponses in Balb/c mouse, SD and RCS rat. Previous studies had
shown that the intraocular injection of Ad-CNTF or rAAV2-CNTF
protected more photoreceptors than injection of recombinant
CNTF (Huang, Zhang, et al., 2004; Huang, Lin, et al., 2004; Liang
et al., 2001). Nevertheless, Ad causes a higher risk of tissue im-
mune responses and Ad-mediated transgene expression lasts for
a shorter period compared to rAAV2 (Flotte, 2007). However, a po-
tential barrier of rAAV2 for retinal gene therapy is its relatively low
transduction efﬁciency to some ocular cells. In this study, we found
that when rAAV2-CNTF (1  109 vg) was combined with AdNull at
a dose of 1  104 PFU, the combination actually resulted in dramat-
ically enhanced protection of photoreceptors in RCS rats. The dose
of AdNull used here was low enough to elude host defense mech-
anisms that were sensitive to the adenovirus, and the optimal dose
range of adenovirus could be further investigated for future pre-
clinical studies. Noticeably, the enhancement effect of Ad5 on
rAAV2 gene expression could last for at least 10 months, when
Ad5 was already eliminated from the retina; this mechanism
should be further investigated.
1654 J. Wu et al. / Vision Research 48 (2008) 1648–1654Our results indicated that low-level Ad5 could greatly enhance,
accelerate and prolong rAAV2-mediated gene expression in the ret-
ina in vivo and in vitro. Our unpublisheddata showed that Ad5 could
also enhance transduction efﬁciency in retinal cells mediated by
rAAV1/2, rAAV5, and rAAV8 (data not shown). It isworth attempting
when the ocular gene therapy applies to the endothelium of the ret-
inal blood vessel, trabecularmeshwork and some inner retinal cells,
when rAAV-mediated transduction is weak. Therefore, the new
strategy described here provided a simple and feasible method to
improve retinal disease gene therapy.
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